Verdad Advisers »

Organogenesis Hldgs shares owned by Verdad Advisers

Quarter-by-quarter ownership of Organogenesis Hldgs (ORGO) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Organogenesis Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Organogenesis Hldgs held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Organogenesis Hldgs by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $113k 47k 2.43

More positions owned by Verdad Advisers

Apple (AAPL)
Belite Bio Sponsored Ads (BLTE)
ACADIA Pharmaceuticals (ACAD)
Comcast Corp Cl A (CMCSA)
Chatham Lodging Trust (CLDT)
Tenax Therapeutics Com New (TENX)
Slide Ins Hldgs (SLDE)
Zymeworks Del (ZYME)
AMN Healthcare Services (AMN)
X4 Pharmaceuticals Com New (XFOR)
Versant Media Group Com Cl A (VSNT)
NetScout Systems (NTCT)
Aadi Bioscience (WHWK)
Johnson & Johnson (JNJ)
Contineum Therapeutics Cl A (CTNM)

View all positions for Verdad Advisers

Top funds holding Organogenesis Hldgs

Morgan Stanley
Soleus Capital Management
BlackRock
Dimensional Fund Advisors
AQR Capital Management
Vanguard Capital Management
D. E. Shaw & Co
Assenagon Asset Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Vanguard Portfolio Management
Acadian Asset Management
State Street Corporation
Renaissance Technologies
Charles Schwab Investment Management

View all funds holding Organogenesis Hldgs